Johnson & Johnson intends to resume testing its coronavirus vaccine soon

As the WP notes, the company previously reported on the temporary termination of the tests due to the fact that one of their participants suffered a stroke.

Last week, Johnson & Johnson announced the temporary suspension of tests because one of their participants was diagnosed with a certain disease. According to sources, the man suffered a stroke. An independent committee conducted an investigation and found that a new vaccine did not cause the incident.

The publication notes that the person who had a stroke was previously part of the group of subjects given an experimental vaccination. People included in the second group were given a placebo.

According to the newspaper, the stroke “could have been caused by an infection.”

The article states that the tests may resume this week. Johnson & Johnson plans to produce more than 1 billion doses of the vaccine by the end of 2021.